Want to take quizzes and track your credits?
The long-term solution to the coronavirus disease 2019 (COVID-19) pandemic, hopefully, will be a globally implemented, safe vaccination program that has broad clinical and socioeconomic benefits. Dozens of vaccines are in development, with 8 currently in phase 1 trials. Some scenarios predict the earliest, widespread availability of a COVID-19 vaccine to be in 2021.1 As launches of prior mass vaccination programs have demonstrated, careful planning to ensure readiness of both the general public and the health community for a COVID-19 vaccine should begin now.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
Corresponding Author: Sarah Schaffer DeRoo, MD, Division of General and Community Pediatrics, Children’s National Hospital, 111 Michigan Ave NW, Washington, DC 20010 (email@example.com).
Published Online: May 18, 2020. doi:10.1001/jama.2020.8711
Conflict of Interest Disclosures: Dr Fu reported receiving grants from Pfizer Inc. No other disclosures were reported.
You currently have no searches saved.